These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6983902)

  • 1. Comparison of iopamidol with metrizamide in sub-occipital ventriculography/cisternography.
    Macpherson P; Teasdale E
    Br J Radiol; 1982 Jul; 55(655):540-1. PubMed ID: 6983902
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neuroradiological experiences iopamidol, a new non-ionic hydro-soluble contrast medium. Comparison to metrizamide with special considerations of side effects and pharmacodynamics with regard to clinical use (author's transl)].
    Hammer B
    Radiologe; 1981 Jun; 21(6):274-81. PubMed ID: 6973775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of water-soluble contrast media in myelography, cisternography and ventriculography. A review with special reference to metrizamide.
    Skalpe IO
    Acta Radiol Suppl; 1977; 355():359-70. PubMed ID: 400906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The symptomatic complications of iopamidol (Niopam) and metrizamide (Amipaque) following lumbar radiculography.
    Stoddart PG; Watt I
    Br J Radiol; 1984 Apr; 57(676):349-50. PubMed ID: 6704672
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical comparison of metrizamide and iopamidol for myelography.
    Turski PA; Sackett JF; Gentry LR; Strother CM; Matozzi F
    AJNR Am J Neuroradiol; 1983; 4(3):309-11. PubMed ID: 6410729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the acute cardiovascular side effects of iopamidol, metrizamide and amidotrizoate after intracoronary and left ventricular injections].
    Schräder R; Wolpers HG; Hoeft A; Korb H; Hellige G
    Radiologe; 1984 May; 24(5):240-6. PubMed ID: 6463236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iopamidol vs. metrizamide myelography: clinical comparison of side effects.
    Trevisan C; Malaguti C; Manfredini M; Tampieri D
    AJNR Am J Neuroradiol; 1983; 4(3):306-8. PubMed ID: 6410728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adverse reactions during ascending cervical myelography using iopamidol and metrizamide--a double-blind study].
    Bockenheimer S; Eichenlaub H
    Rontgenpraxis; 1986 May; 39(5):171-4. PubMed ID: 3523789
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of radiographic quality and adverse reactions in myelography with iopamidol and metrizamide.
    Bannon KR; Braun IF; Pinto RS; Manuell M; Sudilovsky A; Kricheff II
    AJNR Am J Neuroradiol; 1983; 4(3):312-3. PubMed ID: 6410730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Side effects of 2 water-soluble contrast media used in myelography].
    Caillé JM
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):779-82. PubMed ID: 6689467
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cisternography via computerised tomography: technique and pathophysiology as causes of the side effects (author's transl)].
    Hammer B
    Rontgenblatter; 1981 May; 34(5):185-9. PubMed ID: 7017889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of two non-ionic contrast media, iopamidol and metrizamide, in translumbar aortography.
    Hacking PM; Soppitt D
    Clin Radiol; 1983 Jan; 34(1):87-90. PubMed ID: 6337005
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of iopamidol with three other contrast media in orbital venography/cavernous sinography.
    Macpherson P
    Br J Radiol; 1982 Jul; 55(655):539-40. PubMed ID: 7150905
    [No Abstract]   [Full Text] [Related]  

  • 14. Iopamidol and metrizamide in cervical myelography: side effects, EEG, and CSF changes.
    Moschini L; Manara O; Bonaldi G; Cassinari V; Quilici N; Belloni G
    AJNR Am J Neuroradiol; 1983; 4(3):848-50. PubMed ID: 6410870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arachnoiditis from myelography with iopamidol, metrizamide, and iocarmate compared in the animal model.
    Haughton VM; Ho KC
    Invest Radiol; 1980; 15(6 Suppl):S267. PubMed ID: 7203934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of non-ionogenic contrast media for myelography].
    Sviridov NK; Popova ZP; Varfolomeeva VN
    Zh Vopr Neirokhir Im N N Burdenko; 1984; (4):50-3. PubMed ID: 6388202
    [No Abstract]   [Full Text] [Related]  

  • 17. Iopamidol, a new non-ionic hydrosoluble contrast medium for neuroradiology.
    Hammer B; Lackner W
    Neuroradiology; 1980 Apr; 19(3):119-21. PubMed ID: 6991972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind clinical trial of iopamidol versus metrizamide for lumbosacral myelography.
    Drayer BP; Vassallo C; Sudilovsky A; Luther JS; Wilkins RH; Allen S; Bates M
    J Neurosurg; 1983 Apr; 58(4):531-7. PubMed ID: 6338167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelography with lopamidol.
    Lamb JT; Holland IM
    AJNR Am J Neuroradiol; 1983; 4(3):851-3. PubMed ID: 6410871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double blind study of the toxicity of intrathecal iopamidol and metrizamide in lumbar myelography.
    Vézina JL; Fox AJ
    J Can Assoc Radiol; 1984 Sep; 35(3):257-8. PubMed ID: 6501380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.